It was, therefore, not expected to observe increased GC activity and IgM autoantibodies in the AID-ΔE4a patients whose ability to exert SHM is still preserved with SHM frequencies almost similar to AD-AID patients. This evidence concerns the gene CD40LG and Alzheimer disease.